Real-time enrollment status for this idiopathic pulmonary fibrosis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT05571059 |
| Recruiting Status | Recruiting |
| Condition | Idiopathic Pulmonary Fibrosis |
| Phase | Clinical Trial |
| Target Enrollment | 128 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Cumberland Pharmaceuticals |
| Last Updated on CT.gov | February 4, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT05571059 is currently recruiting participants. This clinical trial study for idiopathic pulmonary fibrosis is actively seeking new participants at 17 locations across the United States. The study is sponsored by Cumberland Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05571059 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05571059 was last updated 3 weeks ago (February 4, 2026). HelloStudys verifies this status automatically.